BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haerzschel A, Catusse J, Hutterer E, Paunovic M, Zirlik K, Eibel H, Krenn PW, Hartmann TN, Burger M. BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia. Ann Hematol 2016;95:1979-88. [PMID: 27542958 DOI: 10.1007/s00277-016-2788-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Bagnara D, Mazzarello AN, Ghiotto F, Colombo M, Cutrona G, Fais F, Ferrarini M. Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia. IJMS 2022;23:14249. [DOI: 10.3390/ijms232214249] [Reference Citation Analysis]
2 Guillamat-prats R, Hering D, Derle A, Rami M, Härdtner C, Santovito D, Rinne P, Bindila L, Hristov M, Pagano S, Vuilleumier N, Schmid S, Janjic A, Enard W, Weber C, Maegdefessel L, Faussner A, Hilgendorf I, Steffens S. GPR55 in B cells limits atherosclerosis development and regulates plasma cell maturation. Nat Cardiovasc Res 2022. [DOI: 10.1038/s44161-022-00155-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hilchey SP, Palshikar MG, Mendelson ES, Shen S, Rasam S, Emo JA, Qu J, Thakar J, Zand MS. Cyclosporine A Modulates LSP1 Protein Levels in Human B Cells to Attenuate B Cell Migration at Low O2 Levels. Life (Basel) 2022;12:1284. [PMID: 36013463 DOI: 10.3390/life12081284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cuesta-Mateos C, Juárez-Sánchez R, Mateu-Albero T, Loscertales J, Mol W, Terrón F, Muñoz-Calleja C. Targeting cancer homing into the lymph node with a novel anti-CCR7 therapeutic antibody: the paradigm of CLL. MAbs 2021;13:1917484. [PMID: 33944659 DOI: 10.1080/19420862.2021.1917484] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Cuesta-Mateos C, Brown JR, Terrón F, Muñoz-Calleja C. Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target. Front Immunol 2021;12:662866. [PMID: 33841445 DOI: 10.3389/fimmu.2021.662866] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
6 Heitmann JS, Märklin M, Truckenmüller FM, Hinterleitner C, Dörfel D, Haap M, Kopp HG, Wirths S, Müller MR. A novel flow cytometry-based assay to measure compromised B cell receptor signaling as a prognostic factor in chronic lymphocytic leukemia. J Leukoc Biol 2020;108:1851-7. [PMID: 32303123 DOI: 10.1002/JLB.5TA0320-411RR] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Dai X, Wu YJ, Jia XY, Chang Y, Wu HX, Wang C, Wei W. Immunoglobulin D (IgD) and IgD receptor expression in diffuse large B-cell lymphoma. Hematology 2019;24:544-51. [PMID: 31315540 DOI: 10.1080/16078454.2019.1642553] [Reference Citation Analysis]
8 Maity PC, Datta M, Nicolò A, Jumaa H. Isotype Specific Assembly of B Cell Antigen Receptors and Synergism With Chemokine Receptor CXCR4. Front Immunol 2018;9:2988. [PMID: 30619343 DOI: 10.3389/fimmu.2018.02988] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Maity PC, Datta M, Nicolò A, Jumaa H. Isotype Specific Assembly of B Cell Antigen Receptors and Synergism With Chemokine Receptor CXCR4. Front Immunol 2018;9:2988. [PMID: 30619343 DOI: 10.3389/fimmu.2018.02988] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Guo A, Lu P, Lee J, Zhen C, Chiosis G, Wang YL. HSP90 stabilizes B-cell receptor kinases in a multi-client interactome: PU-H71 induces CLL apoptosis in a cytoprotective microenvironment. Oncogene 2017;36:3441-9. [PMID: 28114285 DOI: 10.1038/onc.2016.494] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]